These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9392144)

  • 21. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
    Wettergren A
    Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
    [No Abstract]   [Full Text] [Related]  

  • 22. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
    Egan JM; Bulotta A; Hui H; Perfetti R
    Diabetes Metab Res Rev; 2003; 19(2):115-23. PubMed ID: 12673779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incretin research in the development of new strategies of diabetes therapy].
    Göke B; Göke R; Fehmann HC; Arnold R
    Internist (Berl); 1995 Apr; 36(4):343-9. PubMed ID: 7775082
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.
    Nyström T; Gonon AT; Sjöholm A; Pernow J
    Regul Pept; 2005 Feb; 125(1-3):173-7. PubMed ID: 15582729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [GLP-1 and the control of insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.
    Thorens B
    Horm Metab Res; 2004; 36(11-12):766-70. PubMed ID: 15655706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
    During MJ; Cao L; Zuzga DS; Francis JS; Fitzsimons HL; Jiao X; Bland RJ; Klugmann M; Banks WA; Drucker DJ; Haile CN
    Nat Med; 2003 Sep; 9(9):1173-9. PubMed ID: 12925848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.
    Hjorth SA; Schwartz TW
    Acta Physiol Scand; 1996 Jul; 157(3):343-5. PubMed ID: 8830889
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of glucagon-like peptide 1 (GLP-1) in regulation of insulin secretion].
    Radosavljević T; Todorović V; Sikić B
    Srp Arh Celok Lek; 2002; 130(11-12):416-9. PubMed ID: 12751170
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro insulinomimetic [corrected] effects of GLP-1 in liver, muscle and fat.
    Valverde I; Villanueva-Peñacarrillo ML
    Acta Physiol Scand; 1996 Jul; 157(3):359-60. PubMed ID: 8830894
    [No Abstract]   [Full Text] [Related]  

  • 32. Discussing the role of glucagonlike peptide-I.
    Holst JJ; Orskov C
    Diabetes Care; 1992 Oct; 15(10):1440-1. PubMed ID: 1425120
    [No Abstract]   [Full Text] [Related]  

  • 33. Central glucagon-like peptide-I in the control of feeding.
    Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
    Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucagon-like peptide: a therapeutic glimmer.
    Amiel SA
    Lancet; 1994 Jan; 343(8888):4-5. PubMed ID: 7905051
    [No Abstract]   [Full Text] [Related]  

  • 35. Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2.
    Holst JJ
    Regul Pept; 2000 Sep; 93(1-3):45-51. PubMed ID: 11033052
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
    Holst JJ; Deacon CF
    Diabetologia; 2005 Apr; 48(4):612-5. PubMed ID: 15759106
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis.
    Drucker DJ
    Endocrinology; 2003 Dec; 144(12):5145-8. PubMed ID: 14645210
    [No Abstract]   [Full Text] [Related]  

  • 38. Endogenous GLP-1 modulates hippocampal activity in beta-amyloid protein-treated rats.
    Oka J; Suzuki E; Goto N; Kameyama T
    Neuroreport; 1999 Sep; 10(14):2961-4. PubMed ID: 10549805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous GLP-1 is involved in beta-amyloid protein-induced memory impairment and hippocampal neuronal death in rats.
    Oka J; Suzuki E; Kondo Y
    Brain Res; 2000 Sep; 878(1-2):194-8. PubMed ID: 10996151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-hypertensive and natriuretic effect of glucagon-like peptide 1 in Dahl S rats: a novel function for a pleotrophic hormone?
    Vollenweider P
    J Hypertens; 2003 Jun; 21(6):1079-80. PubMed ID: 12777941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.